Format

Send to

Choose Destination
Vet Comp Oncol. 2015 Sep;13(3):288-304. doi: 10.1111/vco.12044. Epub 2013 Jun 7.

Comparative analysis of MAPK and PI3K/AKT pathway activation and inhibition in human and canine melanoma.

Author information

1
Cell and Molecular Biology Program, Department of Clinical Sciences, Colorado State University, Fort Collins, CO, USA.
2
Flint Animal Cancer Center, Veterinary Medical Center, Colorado State University, Fort Collins, CO, USA.

Abstract

The lack of advanced animal models of human cancers is considered a barrier to developing effective therapeutics. Canine and human melanomas are histologically disparate but show similar disease progression and response to therapies. The purpose of these studies was to compare human and canine melanoma tumours and cell lines regarding MAPK and PI3K/AKT signalling dysregulation, and response to select molecularly targeted agents. Pathway activation was investigated via microarray and mutational analysis. Growth inhibition and cell cycle effects were assessed for pathway inhibitors AZD6244 (MAPK) and rapamycin (PI3K/AKT) in human and canine melanoma cells. Human and canine melanoma share similar differential gene expression patterns within the MAPK and PI3K/AKT pathways. Constitutive pathway activation and similar sensitivity to AZD6244 and rapamycin was observed in human and canine cells. These results show that human and canine melanoma share activation and sensitivity to inhibition of cancer-related signalling pathways despite differences in activating mutations.

KEYWORDS:

MAPK; PI3K/AKT pathway; canine; human; melanoma

PMID:
23745794
DOI:
10.1111/vco.12044
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center